市場調查報告書

H1N1疫苗的全球市場

H1N1 Vaccines

出版商 Global Industry Analysts, Inc. 商品編碼 121144
出版日期 內容資訊 英文 76 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
H1N1疫苗的全球市場 H1N1 Vaccines
出版日期: 2019年10月01日內容資訊: 英文 76 Pages
簡介

本報告提供全球H1N1疫苗市場相關調查,彙整今後的市場趨勢預測,產品概要,各地區趨勢,及加入此市場的主要企業的簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球H1N1疫苗市場的企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 日本
    • 加拿大
    • 中國
    • 法國
    • 歐洲
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ABBOTT LABORATORIES
  • BAXTER INTERNATIONAL, INC.
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • HUALAN BIOLOGICAL ENGINEERING, INC.
  • MERCK & CO., INC.
  • 田邊三菱製藥
  • SANOFI
  • SINOVAC BIOTECH LTD.
  • PFIZER

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6274

H1N1 Vaccines market worldwide is projected to grow by US$1.7 Billion, driven by a compounded growth of 4.9%. H1N1 Vaccines, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6 Billion by the year 2025, H1N1 Vaccines will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$59.7 Million to the region's size and clout in the next 5 to 6 years. Over US$49.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, H1N1 Vaccines will reach a market size of US$351.7 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.8% over the next couple of years and add approximately US$498.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Abbott Laboratories, Inc.; Baxter International, Inc.; Cipla Ltd.; GlaxoSmithKline PLC; Hualan Biological Engineering, Inc.; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation; Pfizer, Inc.; Sanofi; Sinovac Biotech Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • H1N1 Vaccines Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: H1N1 Vaccines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: H1N1 Vaccines Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • TABLE 3: United States H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025
  • JAPAN
    • TABLE 4: Japanese Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • CANADA
    • TABLE 5: Canadian H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • CHINA
    • TABLE 6: Chinese H1N1 Vaccines Market Growth Prospects in US$ Million for the Period 2018-2025
  • FRANCE
    • TABLE 7: H1N1 Vaccines Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
  • EUROPE
    • Market Facts & Figures
    • TABLE 8: European H1N1 Vaccines Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 9: European H1N1 Vaccines Market Share Shift by Region/Country: 2019 VS 2025
  • GERMANY
    • TABLE 10: H1N1 Vaccines Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • ITALY
    • TABLE 11: Italian H1N1 Vaccines Market Growth Prospects in US$ Million for the Period 2018-2025
  • UNITED KINGDOM
    • TABLE 12: United Kingdom Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • SPAIN
    • TABLE 13: Spanish H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • RUSSIA
    • TABLE 14: Russian H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025
  • REST OF EUROPE
    • TABLE 15: Rest of Europe H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018-2025
  • ASIA-PACIFIC
    • TABLE 16: Asia-Pacific H1N1 Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 17: Asia-Pacific H1N1 Vaccines Market Share Analysis by Region/Country: 2019 VS 2025
  • AUSTRALIA
    • TABLE 18: H1N1 Vaccines Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • INDIA
    • TABLE 19: Indian H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • SOUTH KOREA
    • TABLE 20: H1N1 Vaccines Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • REST OF ASIA-PACIFIC
    • TABLE 21: Rest of Asia-Pacific Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • LATIN AMERICA
    • TABLE 22: Latin American H1N1 Vaccines Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 23: Latin American H1N1 Vaccines Market Percentage Breakdown of Sales by Region/Country: 2019 and 2025
  • ARGENTINA
    • TABLE 24: Argentinean H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018-2025
  • BRAZIL
    • TABLE 25: H1N1 Vaccines Market in Brazil: Estimates and Projections in US$ Million for the Period 2018-2025
  • MEXICO
    • TABLE 26: H1N1 Vaccines Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • REST OF LATIN AMERICA
    • TABLE 27: Rest of Latin America H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025
  • MIDDLE EAST
    • TABLE 28: The Middle East H1N1 Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 29: The Middle East H1N1 Vaccines Market Share Breakdown by Region/Country: 2019 and 2025
  • IRAN
    • TABLE 30: Iranian Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • ISRAEL
    • TABLE 31: Israeli H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018-2025
  • SAUDI ARABIA
    • TABLE 32: Saudi Arabian H1N1 Vaccines Market Growth Prospects in US$ Million for the Period 2018-2025
  • UNITED ARAB EMIRATES
    • TABLE 33: H1N1 Vaccines Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • REST OF MIDDLE EAST
    • TABLE 34: H1N1 Vaccines Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • AFRICA
    • TABLE 35: African H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • BAXTER INTERNATIONAL, INC.
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • HUALAN BIOLOGICAL ENGINEERING, INC.
  • MERCK & CO., INC.
  • MITSUBISHI TANABE PHARMA CORPORATION
  • SANOFI
  • SINOVAC BIOTECH LTD.
  • PFIZER

V. CURATED RESEARCH

Back to Top